Steven E. Finkelstein

SUNY Upstate Medical University — United States

Immunology and Microbiology · Life Sciences

36h-index8.5kcitations110works1.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(36), CAR-T cell therapy research(22), Cancer Immunotherapy and Biomarkers(18), Prostate Cancer Treatment and Research(17), Immune Cell Function and Interaction(12)

Publications110 total

Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel
Cancer·2026Open Access
Challenges and Opportunities in Evaluating Novel Drug-Radiotherapy Combinations
Cureus·2026Open Access
ACROPath Oligometastases: The American College of Radiation Oncology Clinical Pathway
Cureus·2024Open Access
Image-Guided Superficial Radiation Therapy for Basal and Squamous Cell Carcinomas Produces Excellent Freedom from Recurrence Independent of Risk Factors
Journal of Clinical Medicine·2024· 3 citedOpen Access
Challenges and opportunities for early phase clinical trials of novel drug–radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)
The Lancet Oncology·2024· 5 citedOpen Access
Hemibody Irradiation for Bone Metastases: A Systematic Review and Meta-Analysis
Cureus·2024· 2 citedOpen Access
Supplementary Figure 1 from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Data from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Data from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Supplementary Figure 2 from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Supplementary Figure 2 from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Supplementary Figure 1 from Determinants of Successful CD8<sup>+</sup> T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
2023Open Access
Data from Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
2023Open Access
Supplementary materials from Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
2023Open Access
Supplementary materials from Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
2023Open Access
Data from Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
2023Open Access
A Clinician's Guide to Targeted Precision Imaging in Patients With Prostate Cancer (RADAR VI)
JU Open Plus·2022· 10 citedOpen Access
Alleviation of Cancer Therapy-Induced Gastrointestinal Toxicity using an Amino Acid Medical Food
Food & Nutrition Journal·2020· 6 citedOpen Access
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Annals of Internal Medicine·2018· 1 cited
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Clinical Cancer Research·2018· 3 cited
page 1 of 6Next →

Frequent Co-authors

Nicholas P. Restifo(14), Steven A. Rosenberg(10), Christopher A. Klebanoff(8), Douglas C. Palmer(8), Paul A. Antony(7), C.A. Mantz(7), Luca Gattinoni(6), Deborah R. Surman(5), Walter Bosch(5), Mayer Fishman(5), Scott Antonia(5), Paul J. Spiess(4), Leroy N. Hwang(4), Zhiya Yu(4), Christian S. Hinrichs(4), Dian Wang(4), David M. Heimann(3), Marc R. Theoret(3), Ivy A. Petersen(3), Ying J. Hitchcock(3)